Financing options for the treatment of rare diseases in Poland and selected European Union countries

Kliknij autora aby wyszukać wszystkie publikowane przez niego artykuły:
Wojciech Giermaziak, Patrycja Kurowska

3 (52) 2017 s. 349–357
Click to return to issue contents

Digital version of article (in PDF file)

Fraza do cytowania: Giermaziak W., Kurowska P. Financing options for the treatment of rare diseases in Poland and selected European Union countries. Polski Przegląd Nauk o Zdrowiu. 2017;3(52):349–357.

Patients with rare diseases experience difficulties in receiving proper diagnosis and treatment. This review aims to discuss current problems related to the organization and financing of rare diseases treatment in Poland and other European Union countries, as well as solutions that have been applied in some EU countries.

Key words: rare diseases, orphan drug production, drug approval, Poland, European Union.



Copyright © 1989–2018 Polish Review of Health Sciences. All rights reserved.